Literature DB >> 16180119

Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice.

Joe Inoue1, Satoshi Yotsumoto, Takatoshi Sakamoto, Seishi Tsuchiya, Yukihiko Aramaki.   

Abstract

PURPOSE: CpG-oligodeoxynucleotide (CpG-ODN) plays a critical role in immunity via the augmentation of Th1 and the suppression of Th2 responses. We examined here the effect of CpG-ODN on the immune response to an antigen applied to a tape-stripped skin of NC/Nga mouse, a human atopic dermatitis (AD) model, by evaluating the production of cytokines and immunoglobulin isotypes.
METHODS: Model antigen, ovalbumin (OVA), and CpG-ODN were applied on to the shaved skin. The penetration of OVA and CpG-ODN was evaluated using confocal laser scanning microscopy (CLSM). Secretion of cytokine from splenocytes and changes in immunoglobulin isotype levels were determined by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Through CLSM it was revealed that the model antigen, OVA, and CpG-ODN easily penetrated the tape-stripped skin. Coadministration of CpG-ODN and OVA to the skin elicited an antigen-specific, Th1-predominant immune response and enhanced the production of IFN-gamma. On the other hand, the production of a Th2-type cytokine, IL-4, was drastically suppressed. In terms of antigen-specific antibody production, the level of IgG2a regulated by IFN-gamma was increased by CpG-ODN, but IgE production regulated by IL-4 was suppressed.
CONCLUSIONS: Administration of CpG-ODN with antigen through the skin may shift the immune response from a Th2- to Th1-like response. These results suggested that administration of CpG-ODN via skin is a simple strategy for patients with diseases such as AD, which is characterized by Th2-dominated inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16180119     DOI: 10.1007/s11095-005-6834-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  36 in total

Review 1.  T helper type-2 cytokine responses: potential therapeutic targets.

Authors:  Andrew G Jarnicki; Padraic G Fallon
Journal:  Curr Opin Pharmacol       Date:  2003-08       Impact factor: 5.547

2.  Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment.

Authors:  Eduardo Davila; Maria G Velez; Carrie J Heppelmann; Esteban Celis
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

Review 3.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

4.  A functional study of the skin barrier to evaporative water loss by means of repeated cellophane-tape stripping.

Authors:  P G van der Valk; H I Maibach
Journal:  Clin Exp Dermatol       Date:  1990-05       Impact factor: 3.470

5.  The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

Review 6.  Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease.

Authors:  M Yazdanbakhsh; A van den Biggelaar; R M Maizels
Journal:  Trends Immunol       Date:  2001-07       Impact factor: 16.687

7.  Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice.

Authors:  Barbara Spies; Hubertus Hochrein; Martin Vabulas; Katharina Huster; Dirk H Busch; Frank Schmitz; Antje Heit; Hermann Wagner
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

8.  Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin.

Authors:  Ling Liu; Xiaohui Zhou; Jianying Shi; Xin Xie; Zhenghong Yuan
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

9.  Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model.

Authors:  H Nakamura; M Aoki; K Tamai; M Oishi; T Ogihara; Y Kaneda; R Morishita
Journal:  Gene Ther       Date:  2002-09       Impact factor: 5.250

10.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  4 in total

1.  Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants.

Authors:  Momoko Kitaoka; Ayaka Naritomi; Yuya Hirakawa; Noriho Kamiya; Masahiro Goto
Journal:  Pharm Res       Date:  2014-11-01       Impact factor: 4.200

2.  Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.

Authors:  Xinyuan Chen; Dilip Shah; Garuna Kositratna; Dieter Manstein; Richard R Anderson; Mei X Wu
Journal:  J Control Release       Date:  2012-01-09       Impact factor: 9.776

3.  Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14.

Authors:  Sachiko Watanabe; Yoshio Kumazawa; Joe Inoue
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

4.  Intracellular delivery of lipopolysaccharide induces effective Th1-immune responses independent of IL-12.

Authors:  Sachiko Watanabe; Joe Inoue
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.